/ALQGC.PA
ALQGC.PA Stock - Quantum Genomics S.A.
Healthcare|BiotechnologyPAR
$0.07+0.00%
+$0.00 (+0.00%) • Oct 24
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.32
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.08
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ALQGC.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.07 – $0.07
TARGET (TP)$0.08
STOP LOSS$0.07
RISK/REWARD1:3.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.16
52W High$0.15
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $10 | $19,796 | $2.52M | $3.14M | $1.83M |
| Gross Profit | $-1,145,307 | $-1,419,289 | $-26,987,257 | $-17,206,000 | $-14,905,000 |
| Gross Margin | -11453070.0% | -7169.6% | -1073.0% | -548.3% | -814.9% |
| Operating Income | $-1,472,835 | $-3,137,254 | $-30,083,167 | $-20,113,000 | $-16,832,000 |
| Net Income | $-8,892,603 | $-3,170,947 | $-24,935,499 | $-17,359,000 | $-16,224,000 |
| Net Margin | -88926030.0% | -16018.1% | -991.4% | -553.2% | -887.0% |
| EPS | $-0.13 | $-0.09 | $-0.72 | $-0.64 | $-0.79 |
Company Overview
Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ALQGC.PABeat Rate
43%
Last 7 quarters
Avg Surprise
-121.0%
EPS vs Estimate
Beats / Misses
3/4
Last 12 quarters
Latest EPS
$-0.24
Q4 2024
EPS Surprise History
Q1 21
-778.6%
$-0.54vs$0.08
Q4 21
-21.4%
$-0.23vs$-0.19
Q2 22
-58.8%
$-0.41vs$-0.26
Q4 22
No data
Q2 23
-124.3%
$-0.40vs$-0.18
Q4 23
No data
Q1 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Oct 29, 2024 | — | $-0.24 | — | — |
Q1 2024 | Mar 13, 2024 | — | $-0.03 | — | — |
Q4 2023 | Oct 24, 2023 | — | $-0.06 | — | — |
Q2 2023 | May 26, 2023 | $-0.18 | $-0.40 | -124.3% | ✗ MISS |
Q4 2022 | Oct 5, 2022 | — | $-0.40 | — | — |
Q2 2022 | May 2, 2022 | $-0.26 | $-0.41 | -58.8% | ✗ MISS |
Q4 2021 | Oct 6, 2021 | $-0.19 | $-0.23 | -21.4% | ✗ MISS |
Q1 2021 | Mar 25, 2021 | $0.08 | $-0.54 | -778.6% | ✗ MISS |
Q4 2020 | Oct 1, 2020 | $-0.31 | $-0.25 | +19.4% | ✓ BEAT |
Q1 2020 | Mar 27, 2020 | $-0.62 | $-0.28 | +55.6% | ✓ BEAT |
Q4 2019 | Oct 3, 2019 | $-0.63 | $-0.25 | +61.0% | ✓ BEAT |
Q1 2019 | Mar 28, 2019 | — | $-0.37 | — | — |
Q4 2018 | Oct 4, 2018 | — | $-0.54 | — | — |
Q1 2018 | Mar 29, 2018 | — | $-0.49 | — | — |
Q4 2017 | Oct 3, 2017 | — | $-0.46 | — | — |
Q2 2017 | May 29, 2017 | — | $-0.30 | — | — |
Q4 2016 | Oct 13, 2016 | — | $-0.30 | — | — |
Q2 2016 | Apr 14, 2016 | — | $-0.28 | — | — |
Q4 2015 | Oct 15, 2015 | — | $-0.26 | — | — |
Q2 2015 | Apr 23, 2015 | — | $-0.19 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ALQGC.PA
What is ALQGC.PA's current stock price?
Quantum Genomics S.A. (ALQGC.PA) is currently trading at $0.07 per share. The stock has moved +0.00% today.
What is the analyst price target for ALQGC.PA?
No analyst price targets are currently available for this stock.
What sector is Quantum Genomics S.A. in?
Quantum Genomics S.A. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the PAR exchange.
What is ALQGC.PA's market cap?
Quantum Genomics S.A. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ALQGC.PA pay dividends?
No, Quantum Genomics S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALACT.PA
Acticor Biotech SAS
$0.25
Mkt Cap: $0.0B
ALCAR.PA
Carmat S.A.
$0.10
Mkt Cap: $0.0B
ALDEI.PA
Deinove S.A.
$0.03
Mkt Cap: $0.0B
ALHYG.PA
Hybrigenics S.A.
$0.01
Mkt Cap: $0.0B
ALMDP.PA
Medesis Pharma S.A.
$0.35
Mkt Cap: $0.0B
ALPHA.PA
Pharnext S.A.
$0.00
Mkt Cap: $0.0B
APM.PA
Aptorum Group Limited
$3.21
Mkt Cap: $0.0B
LYS.PA
Lysogene S.A.
$0.28
Mkt Cap: $0.0B
MLAHC.PA
Health S.A.
$0.60
Mkt Cap: $0.0B
PHXM.PA
PHAXIAM Therapeutics S.A.
$0.10
Mkt Cap: $0.0B
Explore stocks similar to ALQGC.PA for comparison